Status:
UNKNOWN
Impact of an Olfactory Sensory Therapeutic Group for Adolescent Patients With Restrictive Anorexia Nervosa , Pilot Study
Lead Sponsor:
Fondation Lenval
Conditions:
Anorexia Nervosa
Eligibility:
All Genders
12-20 years
Phase:
NA
Brief Summary
Anorexia nervosa is a severe eating disorder of multifactorial origin and for which there is, to date, no specific, standardized and protocolized management for anorexic patients or data on the superi...
Detailed Description
Currently, there is no specific consensus on the treatment of anorexia nervosa due to a lack of international scientific evidence. The guidelines recommend that patients be managed on an outpatient ba...
Eligibility Criteria
Inclusion
- Aged from 12 to 20 years old
- Diagnosed with restrictive anorexia nervosa, according to Diagnostic and Statistical Manual 5 (DSM 5) criteria and who have not yet entered the care pathway
- Affiliated with the social security scheme
- Good understanding of written and oral French
- Collection of informed consent from the adult subject
- Collection of informed consent from one of the two parents or holder of parental authority if the subject is a minor
Exclusion
- All pathologies that may explain an olfactory sensory disorder: genetic, neurological, neurosensory or rhino laryngeal pathologies (chronic bronchitis, polyps, etc.)
- History of participation in an olfactory sensory therapy group
- The restriction disorder or avoidance of food intake (ARFID, Avoidant and Restrictive Food Intake Disorder)
- Active smoking
- Intellectual disability (ITQ \<70)
- Known allergy to essential or fragrant oils
- A urine pregnancy test will be performed for young women of childbearing age.
- Persons deprived of their liberty by a judicial or administrative decision, persons undergoing psychiatric treatment by virtue of ..
- Adults who are the subject of a legal protection measure or who are unable to express their consent.
- Foreseeable inability to comply with the instructions defined and exposed upon inclusion
Key Trial Info
Start Date :
September 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04883554
Start Date
September 28 2021
End Date
September 1 2024
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Pédiatriques de Nice CHU-Lenval
Nice, France